文献速递头颈外科

口咽癌治疗患者的慢性阿片类药物使用

Chronic opioid use in patients undergoing treatment for oropharyngeal cancer.
PubMed 文献 · Laryngoscope · 2019-01-06

这项回顾性队列研究纳入2012至2017年单中心接受放疗的198例口咽癌患者,评估阿片类药物使用特征及慢性阿片使用危险因素。53%的患者存在慢性阿片使用;单因素分析显示年龄≤62岁、抑郁史、p16阴性、治疗前就诊时阿片使用及诊断时存在慢性疼痛与慢性阿片使用相关;多因素分析显示T分期和焦虑/抑郁与慢性阿片使用相关。慢性阿片使用患者总生存较差,但考虑复发后不显著。

要点

  • 本队列中53%的口咽癌放疗患者存在慢性阿片类药物使用。
  • 单因素分析中年龄≤62岁、抑郁史、p16阴性、治疗前阿片使用及慢性疼痛与慢性阿片使用相关。
  • 多因素分析中T分期和焦虑/抑郁与慢性阿片使用相关。

核心结论

  • 本队列中超过50%接受治疗的口咽鳞状细胞癌患者在治疗后为慢性阿片使用者。
  • 治疗前识别慢性阿片使用风险最高的患者可能有助于该人群的长期疼痛管理。

研究设计与样本

  • 回顾性队列研究,纳入2012至2017年单中心接受放疗作为口咽癌治疗一部分的198例符合条件患者。
  • 通过病理报告审查确定p16/人乳头瘤病毒(HPV)状态,并记录阿片类药物使用。
  • 进行统计分析以评估慢性阿片使用的危险因素及其对总生存的影响。

主要发现

  • 平均年龄62岁,平均随访38个月。
  • 83%的患者为III/IV期疾病,73%接受放化疗,69%为HPV/p16阳性。
  • 57例(29%)患者存在既存慢性疼痛状况。
  • 53%的患者观察到慢性阿片使用。
  • 单因素分析显示年龄≤62岁(P < .0001)、抑郁史(P = .0356)、p16阴性状态(P = .0097)、治疗前就诊时阿片使用(P = .0021)及诊断时存在既存慢性疼痛状况(P = .0181)与慢性阿片使用相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Head and neck cancer pain is a prevalent problem, and the current opioid crisis has highlighted concerns raised in chronic pain management. This study assessed the characteristics of opioid use in patients undergoing treatment for oropharynx cancer and identified risk factors associated with chronic opioid use. STUDY DESIGN: Retrospective cohort study. METHODS: A study was conducted of 198 eligible patients who underwent radiotherapy as part of their treatment for oropharynx cancer at a single institution from 2012 to 2017. p16/human papillomavirus (HPV) status was determined by pathology report review. Opioid use was recorded. Statistical analysis was performed to assess risk factors for chronic opioid use and effect on overall survival. RESULTS: The average age was 62 years, and the mean follow-up was 38 months. Eighty-three percent of patients had stage III/IV disease, and 73% received chemoradiotherapy. Sixty-nine percent were HPV/p16 positive. Fifty-seven (29%) patients had preexisting chronic pain conditions. Chronic opioid use was observed in 53% of the patients. Age ≤ 62 years (P < .0001), history of depression (P = .0356), p16 negative status (P = .0097), opioid use at pretreatment visit (P = .0021), and presence of a preexisting chronic pain condition at time of diagnosis (P = .0181) were associated with chronic opioid use using univariate analysis. On multivariate analysis, T stage and anxiety/depression were associated with chronic opioid use. Overall survival was worse for patients who had chronic opioid use, but was not significant when recurrence was taken into consideration. CONCLUSIONS: More than 50% of the patients treated for oropharynx squamous cell carcinoma in this cohort were chronic opioid users after treatment. Identifying patients at greatest risk for chronic opioid use prior to treatment may help with long-term pain management in this patient population. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:2087-2093, 2019.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Silver N, Dourado J, Hitchcock K, et al. Chronic opioid use in patients undergoing treatment for oropharyngeal cancer. Laryngoscope. 2019. PMID: 30613983. doi:10.1002/lary.27791

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。